GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NEOFECT Co Ltd (XKRX:290660) » Definitions » Operating Margin %

NEOFECT Co (XKRX:290660) Operating Margin % : 0.11% (As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is NEOFECT Co Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. NEOFECT Co's Operating Income for the three months ended in Dec. 2024 was ₩7 Mil. NEOFECT Co's Revenue for the three months ended in Dec. 2024 was ₩6,467 Mil. Therefore, NEOFECT Co's Operating Margin % for the quarter that ended in Dec. 2024 was 0.11%.

Good Sign:

NEOFECT Co Ltd operating margin is expanding. Margin expansion is usually a good sign.

The historical rank and industry rank for NEOFECT Co's Operating Margin % or its related term are showing as below:

XKRX:290660' s Operating Margin % Range Over the Past 10 Years
Min: -178.81   Med: -76.27   Max: -6.68
Current: -11.43


XKRX:290660's Operating Margin % is ranked worse than
62.25% of 816 companies
in the Medical Devices & Instruments industry
Industry Median: 1.745 vs XKRX:290660: -11.43

NEOFECT Co's 5-Year Average Operating Margin % Growth Rate was 41.60% per year.

NEOFECT Co's Operating Income for the three months ended in Dec. 2024 was ₩7 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-2,412 Mil.

Warning Sign:

NEOFECT Co Ltd had lost money in 75% of the time over the past 12quarters.


NEOFECT Co Operating Margin % Historical Data

The historical data trend for NEOFECT Co's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NEOFECT Co Operating Margin % Chart

NEOFECT Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Operating Margin %
Get a 7-Day Free Trial Premium Member Only -76.27 -33.10 -28.77 -6.68 -11.43

NEOFECT Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.49 -32.34 -7.43 -11.76 0.11

Competitive Comparison of NEOFECT Co's Operating Margin %

For the Medical Devices subindustry, NEOFECT Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NEOFECT Co's Operating Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NEOFECT Co's Operating Margin % distribution charts can be found below:

* The bar in red indicates where NEOFECT Co's Operating Margin % falls into.


;
;

NEOFECT Co Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

NEOFECT Co's Operating Margin % for the fiscal year that ended in Dec. 2024 is calculated as

Operating Margin %=Operating Income (A: Dec. 2024 ) / Revenue (A: Dec. 2024 )
=-2412.161 / 21111.728
=-11.43 %

NEOFECT Co's Operating Margin % for the quarter that ended in Dec. 2024 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2024 ) / Revenue (Q: Dec. 2024 )
=7.397 / 6466.739
=0.11 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NEOFECT Co  (XKRX:290660) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


NEOFECT Co Operating Margin % Related Terms

Thank you for viewing the detailed overview of NEOFECT Co's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


NEOFECT Co Business Description

Traded in Other Exchanges
N/A
Address
152, Jukjeon-ro, 401 West Hall, Dankook, University, 152, Suji-gu, Gyeonggi-do, Yongin-si, KOR
NEOFECT Co Ltd is a Korea based company engaged in developing rehab training products and services. The company has developed innovative smart rehabilitation solutions to help patients with neurological and musculoskeletal injuries. Products offered by the company include RAPAEL Smart Glove, RAPAEL Smart Kids, RAPAEL Smart Board, RAPAEL SMART PEGBOARD, RAPAEL Cognition, NeoMano, and RAPAEL Suite.

NEOFECT Co Headlines

No Headlines